Top

Published in:

01-11-2015 | Original Article

Impact of thin-cap fibroatheroma on predicting deteriorated coronary flow during interventional procedures in acute as well as stable coronary syndromes: insights from optical coherence tomography analysis

Authors: Tadatsugu Gamou, Kenji Sakata, Takao Matsubara, Toshihiko Yasuda, Kenji Miwa, Masaru Inoue, Honin Kanaya, Tetsuo Konno, Kenshi Hayashi, Masaaki Kawashiri, Masakazu Yamagishi

Published in: Heart and Vessels | Issue 6/2015

Abstract

The occurrence of deteriorated coronary flow associated with distal embolization during percutaneous coronary intervention results in impaired myocardial perfusion and worsens the clinical prognosis. This study aimed to examine the impact of optical coherence tomography (OCT)-determined coronary plaque morphology on the prediction of deteriorated coronary flow after stent implantation in acute as well as stable coronary syndromes (ACS and SAP, respectively). We studied 126 patients who underwent OCT during stenting for ACS (n = 44) and SAP (n = 82) with a de novo lesion. Angiographic deteriorated coronary flow was defined as the deterioration of TIMI flow grade after mechanical dilatation in the absence of a mechanical obstruction on angiograms. Patients could be divided into the deteriorated flow group (n = 21) and the reflow group (n = 105). Under these conditions, the presence of thin-cap fibroatheroma (TCFA) was more frequently observed in the deteriorated flow group than in the reflow group in both ACS and SAP. A multivariable logistic regression model revealed that TCFA was an independent predictor of deteriorated coronary flow (hazard ratio: 12.32; 95 % confidence interval: 3.02–50.31; p = 0.0005). These results demonstrate that TCFA detected by OCT could be a strong predictor of the occurrence of deteriorated coronary flow during stent implantation in ACS as well as SAP.

Ndrepepa G, Tiroch K, Fusaro M, Keta D, Seyfarth M, Byrne RA, Pache J, Alger P, Mehilli J, Schömig A, Kastrati A (2010) 5 year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 55:2383–2389CrossRefPubMed

Henriques J, Zijlstra F, Ottervanger J, de Boer M, van’t Hof A, Hoorntje J, Suryapranata H (2002) Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 23:1112–1117CrossRefPubMed

Kimura S, Kakuta T, Yonetsu T, Suzuki A, Iesaka Y, Fujiwara H, Isobe M (2009) Clinical significance of echo signal attenuation on intravascular ultrasound in patients with coronary artery disease. Circ Cardiovasc Interv 2:444–454CrossRefPubMed

Chan W, Stub D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan AL, New G, Black A, Shaw JA, Reid CM, Dart AM, Duffy SJ (2012) Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Am J Cardiol 109:478–485CrossRefPubMed

Porto I, Belloni F, Niccoli G, Larosa C, Leone AM, Burzotta F, Trani C, De Maria GL, Hamilton-Craig C, Crea F (2011) Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: incidence, predictors and effect of the type of protection device. EuroIntervention 7:955–961CrossRefPubMed

Umeda H, Katoh T, Iwase M, Izawa H, Nagata K, Watanabe K, Okada T, Yamada T, Tani T, Matsushita T, Murakami Y, Okamoto M, Shimizu T, Murohara T, Yokota M (2006) The distal protection during primary percutaneous coronary intervention alleviates the adverse effects of large thrombus burden on myocardial reperfusion. Circ J 70:232–238CrossRefPubMed

Mizote I, Ueda Y, Ohtani T, Shimizu M, Takeda Y, Oka T, Tsujimoto M, Hirayama A, Hori M, Kodama K (2005) Distal protection improved reperfusion and reduced left ventricular dysfunction in patients with acute myocardial infarction who had angioscopically defined ruptured plaque. Circulation 112:1001–1007CrossRefPubMed

Yundai C, Changhua W, Xinchun Y, Lefeng W, Zhijun S, Hongbin L, Lian C (2012) Independent no-reflow predictors in female patients with ST-elevation acute myocardial infarction treated with primary percutaneous coronary intervention. Heart Vessels 27:243–249CrossRef

Fukuda D, Tanaka A, Shimada K, Nishida Y, Kawarabayashi T, Yoshikawa J (2003) Predicting angiographic distal embolization following percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol 93:403–407CrossRef

10.

Tanaka A, Kawarabayashi T, Nishibori Y, Sano T, Nishida Y, Fukuda D, Shimada K, Yoshikawa J (2002) No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 105:2148–2152CrossRefPubMed

11.

Watanabe T, Nanto S, Uematsu M, Ohara T, Morozumi T, Kotani Ji, Nishio M, Awata M, Nagata S, Hori M (2003) Prediction of no-reflow phenomenon after successful percutaneous coronary intervention in patients with acute myocardial infarction -intravascular ultrasound findings-. Circ J 67:667–671CrossRefPubMed

12.

Lee SY, Mintz GS, Kim SY, Hong YJ, Kim SW, Okabe T, Pichard AD, Satler LF, Kent KM, Suddath WO, Waksman R, Weissman NJ (2009) Attenuated plaque detected by intravascular ultrasound: clinical, angiographic, and morphologic features and post-percutaneous coronary intervention complications in patients with acute coronary syndromes. J Am Coll Cardiol Intv 2:65–72CrossRef

13.

Hong YJ, Jeong MH, Choi YH, Ko JS, Lee MG, Kang WY, Lee SE, Kim SH, Park KH, Sim DS, Yoon NS, Youn HJ, Kim KH, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC (2011) Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis. Eur Heart J 32:2059–2066PubMedCentralCrossRefPubMed

14.

Sakata K, Kawashiri MA, Ino H, Matsubara T, Uno Y, Yasuda T, Miwa K, Kanaya H, Yamagishi M (2012) Intravascular ultrasound appearance of scattered necrotic core as an index for deterioration of coronary flow during intervention in acute coronary syndrome. Heart Vessels 5:443–452CrossRef

15.

Sakata K, Namura M, Takagi T, Tama N, Inoki I, Terai H, Horita Y, Ikeda M, Yamagishi M (2014) Repeated occurrence of slow flow phenomenon during and late after sirolimus-eluting stent implantation. Heart Vessels. doi:10.1007/s00380-014-0477-8

16.

Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, Tanimoto T, Matsuo Y, Masho T, Kitabata H, Tsuda K, Tomobuchi Y, Akasaka T (2007) Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol 50:933–939CrossRefPubMed

17.

Hiro T, Kimura T, Morimoto T, Miyauchi K, Nakagawa Y, Yamagishi M, Ozaki Y, Kimura K, Saito S, Yamaguchi T, Daida H, Matsuzaki M (2009) Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (japan-acs [japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). J Am Coll Cardiol 54:293–302CrossRefPubMed

18.

Lee T, Yonetsu T, Koura K, Hishikari K, Murai T, Iwai T, Takagi T, Iesaka Y, Fujiwara H, Isobe M, Kakuta T (2011) Impact of coronary plaque morphology assessed by optical coherence tomography on cardiac troponin elevation in patients with elective stent implantation. Circ Cardiovasc Interv 4:378–386CrossRefPubMed

19.

The TIMI III, Investigators B (1994) Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-q-wave myocardial infarction. Results of the TIMI III B trial. Thrombolysis in myocardial ischemia. Circulation 89:1545–1556

20.

Porto I, Choudhury RP, Pillay P, Burzotta F, Trani C, Niccoli G, Blackman DJ, Channon KM, Banning AP (2006) Filter no reflow during percutaneous coronary interventions using the filterwire distal protection device. Int J Cardiol 109:53–58CrossRefPubMed

21.

Yabushita H, Bouma BE, Houser SL, Aretz HT, Jang IK, Schlendorf KH, Kauffman CR, Shishkov M, Kang DH, Halpern EF, Tearney GJ (2002) Characterization of human atherosclerosis by optical coherence tomography. Circulation 106:1640–1645CrossRefPubMed

22.

Bae JH, Kwon TG, Hyun DW, Rihal CS, Lerman A (2008) Predictors of slow flow during primary percutaneous coronary intervention: an intravascular ultrasound-virtual histology study. Heart 94:1559–1564CrossRefPubMed

23.

Jaffe R, Charron T, Puley G, Dick A, Strauss BH (2008) Microvascular obstruction and the no-reflow phenomenon after percutaneous coronary intervention. Circulation 117:3152–3156CrossRefPubMed

24.

Singh M, Berger P, Ting H, Rihal C, Wilson S, Lennon R, Reeder G, Bresnahan J, Holmes J (2001) Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the mayo clinic experience). Am J Cardiol 88:1091–1096CrossRefPubMed

25.

Kusama I, Hibi K, Kosuge M, Nozawa N, Ozaki H, Yano H, Sumita S, Tsukahara K, Okuda J, Ebina T, Umemura S, Kimura K (2007) Impact of plaque rupture on infarct size in st-segment elevation anterior acute myocardial infarction. J Am Coll Cardiol 50:1230–1237CrossRefPubMed

26.

Kodama T, Kondo T, Oida A, Fujimoto S, Narula J (2012) Computed tomographic angiography-verified plaque characteristics and slow-flow phenomenon during percutaneous coronary intervention. JACC Cardiovasc Interv 5:636–643CrossRefPubMed

27.

McEntegart MB, Kirtane AJ, Cristea E, Brener S, Mehran R, Fahy M, Moses JW, Stone GW (2012) Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-st-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the acuity (acute catheterization and urgent intervention triage strategy) trial. J Am Coll Cardiol 59:1745–1751CrossRefPubMed

28.

De Luca G, Suryapranata H, Stone GW, Antoniucci D, Neumann FJ, Chiariello M (2007) Adjunctive mechanical devices to prevent distal embolization in patients undergoing mechanical revascularization for acute myocardial infarction: a meta-analysis of randomized trials. Am Heart J 153:343–353CrossRefPubMed

29.

Lee T, Kakuta T, Yonetsu T, Takahashi K, Yamamoto G, Iesaka Y, Fujiwara H, Isobe M (2011) Assessment of echo-attenuated plaque by optical coherence tomography and its impact on post-procedural creatine kinase-myocardial band elevation in elective stent implantation. J Am Coll Cardiol Intv 4:483–491CrossRef

30.

Takarada S, Imanishi T, Liu Y, Ikejima H, Tsujioka H, Kuroi A, Ishibashi K, Komukai K, Tanimoto T, Ino Y, Kitabata H, Kubo T, Nakamura N, Hirata K, Tanaka A, Mizukoshi M, Akasaka T (2010) Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion. Catheter Cardiovasc Interv 75:202–206CrossRefPubMed

Title: Impact of thin-cap fibroatheroma on predicting deteriorated coronary flow during interventional procedures in acute as well as stable coronary syndromes: insights from optical coherence tomography analysis
Authors: Tadatsugu Gamou
Kenji Sakata
Takao Matsubara
Toshihiko Yasuda
Kenji Miwa
Masaru Inoue
Honin Kanaya
Tetsuo Konno
Kenshi Hayashi
Masaaki Kawashiri
Masakazu Yamagishi
Publication date: 01-11-2015
Publisher: Springer Japan
Published in: Heart and Vessels / Issue 6/2015
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI: https://doi.org/10.1007/s00380-014-0542-3

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Impact of thin-cap fibroatheroma on predicting deteriorated coronary flow during interventional procedures in acute as well as stable coronary syndromes: insights from optical coherence tomography analysis

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2015

Usefulness of serum bilirubin levels as a biomarker for long-term clinical outcomes after percutaneous coronary intervention

Acknowledgment to reviewers

A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia

First clinical experience of the looped Inoue balloon technique for antegrade percutaneous balloon aortic valvuloplasty

Effect of novel modified bipolar radiofrequency ablation for preoperative atrial fibrillation combined with off-pump coronary artery bypass grafting surgery

Is pentraxin 3 a biomarker, a player, or both in the context of coronary atherosclerosis and metabolic factors?

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page